Status:
UNKNOWN
Combination With Intranasal Dexmedetomidine and Oral Midazolam for Premedication in Pediatric Patients
Lead Sponsor:
Second Affiliated Hospital of Wenzhou Medical University
Conditions:
Anxiety
Eligibility:
All Genders
2-6 years
Phase:
PHASE4
Brief Summary
Children tend to anxiety and even fear before survey. And this kind of anxiety will not result in the forced induction of anesthesia, but also may increase the incidence of postoperative agitation in ...
Detailed Description
A trained member of the research team obtained a baseline The Modified Yale Preoperative Anxiety Scale(mYPAS) after obtaining consent. And corresponding study medication is administered about 30-40 mi...
Eligibility Criteria
Inclusion
- with American Society of Anesthesiologists (ASA) physical status I or II；
- aged 2-6 years；
- children with weight for age within the normal range
- were scheduled lower abdominal and perineal surgery with an expected operation time shorter than 30 minutes.
Exclusion
- Children who had gastrointestinal,Cardiovascular or endocrine dysfunction;
- contraindication to preoperative sedation or had a known allergy or hypersensitive reaction to either dexmedetomidine or midazolam;
- with any nasal pathology,organ dysfunction;
- recently respiratory infection, mental disorder;
- other reasons that researchers hold it is not appropriate to participate in this trial.
Key Trial Info
Start Date :
October 25 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2020
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT04135014
Start Date
October 25 2019
End Date
October 1 2020
Last Update
November 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China